Shield Therapeutics inks licencing agreement for iron deficiency drug
(Alliance News) - Shield Therapeutics PLC on Tuesday reported an exclusive deal with a Japanese distributor, as it looks keep expanding Accrufer's global footprint. Read More
Price | 2.425p on 18-06-2025 | at 17:45:04
---|---|
Change | -0.10p -3.96% |
Buy | 2.55p |
Sell | 2.30p |
Buy / Sell STX Shares |
Last Trade: | Buy 3,984.00 at 2.51p |
Day's Volume: | 727,128 |
Last Close: | 2.425p |
Open: | 2.525p |
ISIN: | GB00BYV81293 |
Day's Range | 2.425p - 2.525p |
52wk Range: | 1.525p - 5.80p |
Market Capitalisation: | £25m |
VWAP: | 2.47729p |
Shares in Issue: | 1,042m |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Shield Thera (STX) Latest Trades |
||||
Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
---|---|---|---|---|
Buy* | 3,984 | 2.51p | Ordinary |
15:57:03 - 18-Jun-25 |
Sell* | 964 | 2.30p | SI Trade |
15:44:21 - 18-Jun-25 |
Buy* | 75,972 | 2.50p | Ordinary |
15:40:15 - 18-Jun-25 |
Buy* | 250,000 | 2.485p | Ordinary |
14:50:44 - 18-Jun-25 |
Buy* | 41 | 2.55p | SI Trade |
14:48:52 - 18-Jun-25 |
Sell* | 125,000 | 2.45p | Ordinary |
14:48:26 - 18-Jun-25 |
Buy* | 3,784 | 2.55p | Ordinary |
11:12:47 - 18-Jun-25 |
Sell* | 39,682 | 2.52p | Ordinary |
10:03:30 - 18-Jun-25 |
Sell* | 143,678 | 2.46p | Ordinary |
09:00:21 - 18-Jun-25 |
Buy* | 82 | 2.60p | SI Trade |
08:58:14 - 18-Jun-25 |
Shield Thera (STX) Regulatory News |
||
Date | Source | Headline |
---|---|---|
22nd May 2025 5:06 pm | RNS | Result of AGM |
24th Apr 2025 7:06 am | RNS | Audited results for the year ended 31 Dec 2024 |
22nd Apr 2025 7:01 am | RNS | Licence Agreement in Japan for ACCRUFeR® |
17th Apr 2025 11:23 am | RNS | Q1 2025 Trading Update |
11th Mar 2025 7:00 am | RNS | ACCRUFeR® launched in Canada |
13th Feb 2025 4:15 pm | RNS | PDMR Transaction Notification |
13th Feb 2025 7:00 am | RNS | Grant of Share Options |
5th Feb 2025 7:00 am | RNS | Unaudited full year trading update |
27th Jan 2025 7:00 am | RNS | Anders Lundstrom appointed CEO |
24th Dec 2024 11:25 am | RNS | Result of General Meeting & Total Voting Rights |